# THCV & Metabolic Pharmacology: Cannabinoid Appetite Regulation > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/videos/thcv-appetite-metabolism/ > **Published:** 2026-10-08T09:55:13-04:00 | **Last Modified / Clinically Audited:** 2026-10-29T11:42:02-04:00 > **Clinical Summary:** CBS News WBZ investigation featuring Dr. Benjamin Caplan on THCV pharmacology, neutral CB1 receptor antagonism, and cannabinoid metabolic regulation. --- [← All Videos & Media](/videos/) Metabolic Science Spotlight Table of Contents - [THCV & Metabolic Pharmacology:The Science of Cannabinoid Appetite Regulation](#THCV_038_Metabolic_PharmacologyThe_Science_of_Cannabinoid_Appetite_Regulation)[Executive Summary: The Cannabis Compound That Curbs Hunger](#Executive_Summary_The_Cannabis_Compound_That_Curbs_Hunger) - [How THCV Modulates the Endocannabinoid System](#How_THCV_Modulates_the_Endocannabinoid_System)[🛑 Neutral CB1 Receptor Antagonism](#_Neutral_CB1_Receptor_Antagonism) - [🩸 Glycemic Control & Insulin Sensitivity](#_Glycemic_Control_038_Insulin_Sensitivity) - [⚡ Clear-Headed Daytime Alertness](#_Clear-Headed_Daytime_Alertness) - [🧬 Pure Botanical vs. Synthetic Loopholes](#_Pure_Botanical_vs_Synthetic_Loopholes) - [Ethan Zohn & Dr. Caplan: Cancer Recovery & Remission Science](#Ethan_Zohn_038_Dr_Caplan_Cancer_Recovery_038_Remission_Science) - [Clinical Comparison: THC vs. THCV vs. CBD](#Clinical_Comparison_THC_vs_THCV_vs_CBD)[The 60-Second Clinic: Instant Video Mythbusters & Receptor Science](#The_60-Second_Clinic_Instant_Video_Mythbusters_038_Receptor_Science) - [Why Minor Cannabinoids Are the Future of Precision Medicine](#Why_Minor_Cannabinoids_Are_the_Future_of_Precision_Medicine) - [Explore More CĒD Clinic Video Channels & Features](#Explore_More_CED_Clinic_Video_Channels_038_Features)[Ethan Zohn & Dr. Caplan: Cancer Recovery](#Ethan_Zohn_038_Dr_Caplan_Cancer_Recovery) - [The Cannabis Heart Paradox](#The_Cannabis_Heart_Paradox) - [The 60-Second Clinic: Bite-Sized Science](#The_60-Second_Clinic_Bite-Sized_Science) - [The Master Media Timeline (2018–2026)](#The_Master_Media_Timeline_20182026) - [Explore Tailored Cannabinoid Regimens at CĒD Clinic](#Explore_Tailored_Cannabinoid_Regimens_at_CED_Clinic)[Recent Clinical Trials & Peer-Reviewed Evidence: Appetite](#Recent_Clinical_Trials_Peer-Reviewed_Evidence_Appetite)[Tetrahydrocannabivarin is Not Tetrahydrocannabinol](#Tetrahydrocannabivarin_is_Not_Tetrahydrocannabinol) - [The CB1 receptor as a convergence hub linking stress, sleep and appetite regulation: An integrative neurobiological model](#The_CB1_receptor_as_a_convergence_hub_linking_stress_sleep_and_appetite_regulation_An_integrative_neurobiological_model) # THCV & Metabolic Pharmacology:The Science of Cannabinoid Appetite Regulation CBS News WBZ Channel 4 investigates the clinical emergence of THCV. Featuring Dr. Benjamin Caplan, MD on how neutral CB1 receptor antagonism curbs appetite, supports metabolic regulation, and changes clinical cannabis therapeutics. 📺 CBS News WBZ Channel 4 🧬 Neutral CB1 Antagonism ⚡ Non-Sedating Daytime Profile ● CBS News Television Broadcast CBS WBZ Boston Channel 4 [▶](https://www.cbsnews.com/boston/news/wareham-cannabis-company-coast-cannabis-gummy-diet-workout/) ### Executive Summary: The Cannabis Compound That Curbs Hunger CBS News visits Wareham, Massachusetts to investigate Coast Cannabis Co. and the surge of consumer interest in THCV-infused gummies. Dr. Benjamin Caplan explains why THCV behaves completely differently from standard THC: by acting as a neutral antagonist at the CB1 receptor, it blocks the physiological appetite triggers commonly known as ‘the munchies,’ promoting metabolic satiety and daytime alertness without the intoxication or lethargy of recreational cannabis. [Watch Full CBS News Report ↗](https://www.cbsnews.com/boston/news/wareham-cannabis-company-coast-cannabis-gummy-diet-workout/) [Consult with Dr. Caplan on Metabolic Regimens ↗](https://cedclinic.com/contact-ced-staff/) Molecular Pharmacology ## How THCV Modulates the Endocannabinoid System Understanding the cellular mechanisms that differentiate Tetrahydrocannabivarin (THCV) from traditional THC. Appetite Regulation #### 🛑 Neutral CB1 Receptor Antagonism While standard THC is a partial agonist at CB1 receptors—triggering intense ghrelin release and hunger cravings—THCV binds as a neutral antagonist at lower clinical doses. It blocks appetite stimulation, promoting natural meal satiety without rebound hunger. Metabolic Balance #### 🩸 Glycemic Control & Insulin Sensitivity Preclinical and clinical trials indicate THCV improves insulin resistance, enhances pancreatic beta-cell function, and reduces fasting plasma glucose levels. This makes it an area of intense research for type 2 diabetes and metabolic syndrome. Non-Sedating Focus #### ⚡ Clear-Headed Daytime Alertness Unlike the heavy physical sedation and cognitive haze often associated with indica-dominant THC strains, THCV is recognized by patients for promoting clean mental clarity, energetic motivation, and enhanced physical stamina during workouts. Quality Assurance #### 🧬 Pure Botanical vs. Synthetic Loopholes Natural THCV is a rare minor cannabinoid produced in specific African landrace genetics. Dr. Caplan emphasizes the critical importance of physician-guided botanical formulations over unregulated, synthetic semi-legal conversions found at gas stations. [▶](/videos/cancer-survivorship-ethan-zohn/) Survivor Champion Dialogue #### Ethan Zohn & Dr. Caplan: Cancer Recovery & Remission Science Witness how clinical cannabinoid protocols helped two-time Hodgkin’s lymphoma survivor Ethan Zohn manage debilitating chemotherapy nausea, radiation recovery, and post-remission PTSD across 6 deep-dive video chapters. [Watch the 6-Part Ethan Zohn Series ↗](/videos/cancer-survivorship-ethan-zohn/) ### Clinical Comparison: THC vs. THCV vs. CBD Property THC (Delta-9) THCV (Cannabivarin) CBD (Cannabidiol) CB1 Receptor Action Partial Agonist (Activates) Neutral Antagonist at low dose (Blocks) Negative Allosteric Modulator Appetite Effect Strongly Stimulates (‘Munchies’) Curbs / Suppresses Hunger Appetite Neutral / Stabilizing Cognitive Effect Intoxicating / Psychoactive Clear-Headed / Energizing Focus Non-Intoxicating / Calming Energy & Motor Profile Sedating / Relaxing Motivating / Physical Stamina Relaxing without Sedation Metabolic Satiety Increases caloric craving Promotes fullness & insulin balance Reduces oxidative stress [▶](/videos/shorts/) Bite-Sized Clinical Video Hub #### The 60-Second Clinic: Instant Video Mythbusters & Receptor Science Explore Dr. Caplan’s interactive video library translating complex minor cannabinoid chemistry, tolerance breaks, and everyday dosing protocols in under 60 seconds with topic filters. [Explore 60-Second Video Library ↗](/videos/shorts/) From Dr. Benjamin Caplan, MD ### Why Minor Cannabinoids Are the Future of Precision Medicine “For decades, the commercial cannabis industry obsessed over single-digit THC percentages, marketing intoxicating potency rather than medical utility. THCV is the definitive antidote to that mindset. It demonstrates that the cannabis plant contains intricate molecular switches capable of regulating appetite, improving metabolic efficiency, and preserving sharp focus. For patients managing diabetes risks, metabolic syndrome, or fatigue, THCV offers targeted pharmacology without the baggage.” — Benjamin Caplan, MD | Chief Medical Officer, CĒD Clinic [Related: Ethan Zohn & Dr. Caplan on THCV in Oncology ↗](/videos/cancer-survivorship-ethan-zohn/) Video Network Directory ### Explore More CĒD Clinic Video Channels & Features Continue your journey through our clinical video library, documentary dialogues, and short-form masterclasses. [Survivor Series Feature ▶](/videos/cancer-survivorship-ethan-zohn/) #### Ethan Zohn & Dr. Caplan: Cancer Recovery 6-part video masterclass with Survivor winner Ethan Zohn exploring chemotherapy nausea, neuropathies, radiation recovery, and post-remission PTSD. [Watch 6-Part Series ↗](/videos/cancer-survivorship-ethan-zohn/) [Cardiology & Vascular Medicine ▶](/videos/cannabis-and-heart-health/) #### The Cannabis Heart Paradox Cannabichem scientific deep dive with Dr. Caplan exploring endothelial signaling, transient autonomic heart rate shifts, and precision clinical risk. [Watch Heart Masterclass ↗](/videos/cannabis-and-heart-health/) [Shorts & TikTok Video Hub ▶](/videos/shorts/) #### The 60-Second Clinic: Bite-Sized Science Interactive vertical video library translating complex pharmacology, dispensary myths, senior wellness, and cannabis law in under 60 seconds. [Browse 60-Second Hub ↗](/videos/shorts/) [Complete Media Archive ▶](/videos/) #### The Master Media Timeline (2018–2026) Full chronological continuum assembling televised leadership across FOX 5 DC, CBS News WBZ, NBC Boston, congressional hearings, and Harvard lectures. [Explore Master Timeline ↗](/videos/) Physician-Guided Care ## Explore Tailored Cannabinoid Regimens at CĒD Clinic Don’t guess your way through dispensaries or risk unverified gas-station products. Schedule a comprehensive consultation with Dr. Benjamin Caplan to evaluate your metabolic profile, drug-drug interactions, and evidence-grounded minor cannabinoid options. [Schedule Your Clinical Consultation ↗](https://cedclinic.com/contact-ced-staff/) [Explore Full Media Timeline ↗](/videos/) Oxford CEBM Graded Research ### Recent Clinical Trials & Peer-Reviewed Evidence: Appetite Clinical studies analyzed and contextualized by Benjamin Caplan, MD (CED Clinic Chief Medical Officer) Oxford CEBM Level 5: Expert Clinical Review Cannabis Cannabinoid Res (2025) #### Tetrahydrocannabivarin is Not Tetrahydrocannabinol This study confirms that tetrahydrocannabivarin and tetrahydrocannabinol are distinct compounds, a fact already well established in clinical practice. [Read Physician Analysis & View Citations →](https://cedclinic.com/research/tetrahydrocannabivarin-is-not-tetrahydrocannabinol-8/) Oxford CEBM Level 5: Expert Clinical Review Neurosci Biobehav Rev (2026) #### The CB1 receptor as a convergence hub linking stress, sleep and appetite regulation: An integrative neurobiological model This conceptual framework helps clinicians view stress, sleep, and appetite as interconnected targets rather than isolated symptoms when considering endocannabinoid modulation, though it does not yet offer specific ... [Read Physician Analysis & View Citations →](https://cedclinic.com/research/the-cb1-receptor-as-a-convergence-hub-linking-stress-sleep-and-appetite-regulation-an-integrative-neurobiological-model-4/) [Explore all peer-reviewed research on Appetite in the Research Hub →](https://cedclinic.com/research-condition/appetite/) --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).